Survivors of pediatric posterior fossa tumors: Cognitive outcome, intervention, and risk-based care

European Journal of Oncology Nursing

Volumn 13, Issue 3, 2009, Pages 171-178

  Palmer, Shawna L ^a   Leigh, Laurie ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

Intervention; Late effects; Pediatric cancer; Survivorship

Indexed keywords

ADAPTIVE BEHAVIOR; ADJUVANT CHEMOTHERAPY; ADJUVANT THERAPY; ADOLESCENT; ADULT; AGE; ARTICLE; CANCER STAGING; CEREBELLUM TUMOR; COGNITIVE DEFECT; EARLY DIAGNOSIS; FEMALE; HUMAN; INTERVENTION STUDY; MALE; METHODOLOGY; MULTIMODALITY CANCER THERAPY; NEUROSURGERY; PATHOPHYSIOLOGY; PATIENT EDUCATION; PROGNOSIS; PSYCHOLOGICAL ASPECT; QUALITY OF LIFE; RISK ASSESSMENT; RISK MANAGEMENT; SEX DIFFERENCE; SICKNESS IMPACT PROFILE; STATISTICS; SURVIVOR; TREATMENT OUTCOME;

ADAPTATION, PSYCHOLOGICAL; ADOLESCENT; AGE FACTORS; CHEMOTHERAPY, ADJUVANT; COGNITION DISORDERS; COMBINED MODALITY THERAPY; EARLY DETECTION OF CANCER; FEMALE; HUMANS; INFRATENTORIAL NEOPLASMS; INTERVENTION STUDIES; MALE; NEOPLASM STAGING; NEUROSURGICAL PROCEDURES; PATIENT EDUCATION AS TOPIC; PROGNOSIS; QUALITY OF LIFE; RADIOTHERAPY, ADJUVANT; RISK ASSESSMENT; RISK MANAGEMENT; SEX FACTORS; SICKNESS IMPACT PROFILE; SURVIVORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 67849103320     PISSN: 14623889     EISSN: 15322122     Source Type: Journal    
DOI: 10.1016/j.ejon.2008.09.002     Document Type: Article

References (59)

1. Bull K.S., Spoudeas H.A., Yadegarfar G., and Kennedy C.R. Reduction of health status 7 years after addition of chemotherapy to craniospinal irradiation for medulloblastoma: a follow-up study in PNET 3 trial survivors on behalf of the CCLG (formerly UKCCSG). J. Clin. Oncol. 25 27 (2007) 4239-4245
2. Butler R.W. Attentional processes and their remediation in childhood cancer. Med. Pediatr. Oncol. Suppl. 1 (1998) 75-78
3. Butler R.W., and Copeland D.R. Attentional processes and their remediation in children treated for cancer: a literature review and the development of a therapeutic approach. J. Int. Neuropsychol. Soc. 8 1 (2002) 115-124
4. Butler R.W., and Mulhern R.K. Neurocognitive interventions for children and adolescents surviving cancer. J. Pediatr. Psychol. 30 1 (2005) 65-78
5. Children's Oncology Group, 2006. Long-term follow-up guidelines for survivors of childhood, adolescent, and young adult cancers.
6. Conklin H.M., Khan R.B., Reddick W.E., Helton S., Brown R., Howard S.C., Bonner M., Christensen R., Wu S., Xiong X., and Mulhern R.K. Acute neurocognitive response to methylphenidate among survivors of childhood cancer: a randomized, double-blind, cross-over trial. J. Pediatr. Psychol. 32 9 (2007) 1127-1139
7. Copeland D.R., deMoor C., Moore III B.D., and Ater J.L. Neurocognitive development of children after a cerebellar tumor in infancy: a longitudinal study. J. Clin. Oncol. 17 11 (1999) 3476-3486
8. Daly B.P., and Brown R.T. Scholarly literature review: management of neurocognitive late effects with stimulant medication. J. Pediatr. Psychol. 32 9 (2007) 1111-1126
9. Dennis M., Hetherington C.R., and Spiegler B.J. Memory and attention after childhood brain tumors. Med. Pediatr. Oncol. Suppl. 1 (1998) 25-33
10. Dennis M., Spiegler B.J., Hetherington C.R., and Greenberg M.L. Neuropsychological sequelae of the treatment of children with medulloblastoma. J. Neurooncol. 29 1 (1996) 91-101
11. Fletcher J.M., Lyon G.R., Fuchs L., and Barnes M. Learning Disabilities: From Identification to Intervention (2007), Guildford, New York
12. Frank B., Schoch B., Richter S., Frings M., Karnath H., and Timmann D. Cerebellar lesion studies of cognitive function in children and adolescents - limitations and negative findings. Cerebellum 6 3 (2007) 242-253
13. Fry A.F., and Hale S. Relationships among processing speed, working memory, and fluid intelligence in children. Biol. Psychol. 54 1-3 (2000) 1-34
14. Gajjar A., Chintagumpala M., Ashley D., Kellie S., Kun L.E., Merchant T.E., Woo S., Wheeler G., Ahern V., Krasin M.J., Fouladi M., Broniscer A., Krance R., Hale G.A., Stewart C.F., Dauser R., Sanford R.A., Fuller C., Lau C., Boyett J.M., Wallace D., and Gilbertson R.J. Risk-adapted craniospinal radiotherapy followed by high-dose chemotherapy and stem-cell rescue in children with newly diagnosed medulloblastoma (St Jude Medulloblastoma-96): long-term results from a prospective, multicentre trial. Lancet Oncol. 7 10 (2006) 813-820
15. Gathercole S.E., and Alloway T.P. Practitioner review: short-term and working memory impairments in neurodevelopmental disorders: diagnosis and remedial support. J. Child Psychol. Psychiatry 47 1 (2006) 4-15
16. Gortmaker V.J., Daly III E.J., McCurdy M., Persampieri M.J., and Hergenrader M. Improving reading outcomes for children with learning disabilities: using brief experimental analysis to develop parent-tutoring interventions. J. Appl. Behav. Anal. 40 2 (2007) 203-221
17. Gottardo N.G., and Gajjar A. Current Therapy for Medulloblastoma. Curr. Treat. Options Neurol. 8 4 (2006) 319-334
18. Kieffer-Renaux V., Bulteau C., Grill J., Kalifa C., Viguier D., and Jambaque I. Patterns of neuropsychological deficits in children with medulloblastoma according to craniospatial irradiation doses. Develop. Med. Child Neurol. 42 (2000) 741-745
19. Landier W., Bhatia S., Eshelman D.A., Forte K.J., Sweeney T., Hester A.L., Darling J., Armstrong F.D., Blatt J., Constine L.S., Freeman C.R., Friedman D.L., Green D.M., Marina N., Meadows A.T., Neglia J.P., Oeffinger K.C., Robison L.L., Ruccione K.S., Sklar C.A., and Hudson M.M. Development of risk-based guidelines for pediatric cancer survivors: the children's oncology group long-term follow-up guidelines from the children's oncology group late effects committee and nursing discipline. J. Clin. Oncol. 22 24 (2004) 4979-4990
20. Mabbott D.J., Penkman L., Witol A., Strother D., and Bouffet E. Core neurocognitive functions in children treated for posterior fossa tumors. Neuropsychology 22 2 (2008) 159-168
21. Mabbott D.J., Spiegler B.J., Greenberg M.L., Rutka J.T., Hyder D.J., and Bouffet E. Serial evaluation of academic and behavioral outcome after treatment with cranial radiation in childhood. J. Clin. Oncol. 23 10 (2005) 2256-2263
22. Maddrey A.M., Bergeron J.A., Lombardo E.R., McDonald N.K., Mulne A.F., Barenberg P.D., and Bowers D.C. Neuropsychological performance and quality of life of 10 year survivors of childhood medulloblastoma. J. Neurooncol. 72 3 (2005) 245-253
23. Merchant T.E., Kiehna E.N., Kun L.E., Mulhern R.K., Li C., Xiong X., Boop F.A., and Sanford R.A. Phase II trial of conformal radiation therapy for pediatric patients with craniopharyngioma and correlation of surgical factors and radiation dosimetry with change in cognitive function. J. Neurosurg. 104 2 Suppl (2006) 94-102
24. Mitby P.A., Robison L.L., Whitton J.A., Zevon M.A., Gibbs I.C., Tersak J.M., Meadows A.T., Stovall M., Zeltzer L.K., and Mertens A.C. Utilization of special education services and educational attainment among long-term survivors of childhood cancer: a report from the childhood cancer survivor study. Cancer 97 4 (2003) 1115-1126
25. Moore III B.D. Neurocognitive outcomes in survivors of childhood cancer. J. Pediatr. Psychol. 30 1 (2005) 51-63
26. Mostow E.N., Byrne J., Connelly R.R., and Mulvihill J.J. Quality of life in long-term survivors of CNS tumors of childhood and adolescence. J. Clin. Oncol. 9 4 (1991) 592-599
27. Mulhern R.K., Hancock J., Fairclough D., and Kun L. Neuropsychological status of children treated for brain tumors: a critical review and integrative analysis. Med. Pediatr. Oncol. 20 3 (1992) 181-191
28. Mulhern R.K., Kepner J.L., Thomas P.R., Armstrong F.D., Friedman H.S., and Kun L.E. Neuropsychologic functioning of survivors of childhood medulloblastoma randomized to receive conventional or reduced-dose craniospinal irradiation: a Pediatric Oncology Group study. J. Clin. Oncol. 16 5 (1998) 1723-1728
29. Mulhern R.K., Merchant T.E., Gajjar A., Reddick W.E., and Kun L.E. Late neurocognitive sequelae in survivors of brain tumours in childhood. Lancet Oncol. 5 7 (2004) 399-408
30. Mulhern R.K., and Palmer S.L. Neurocognitive late effects in pediatric cancer. Curr. Probl. Cancer 27 4 (2003) 177-197
31. Mulhern R.K., Palmer S.L., Merchant T.E., Wallace D., Kocak M., Brouwers P., Krull K., Chintagumpala M., Stargatt R., Ashley D.M., Tyc V.L., Kun L., Boyett J., and Gajjar A. Neurocognitive consequences of risk-adapted therapy for childhood medulloblastoma. J. Clin. Oncol. 23 24 (2005) 5511-5519
32. Mulhern R.K., Palmer S.L., Reddick W.E., Glass J.O., Kun L.E., Taylor J., Langston J., and Gajjar A. Risks of young age for selected neurocognitive deficits in medulloblastoma are associated with white matter loss. J. Clin. Oncol. 19 2 (2001) 472-479
33. Nagel B.J., Delis D.C., Palmer S.L., Reeves C., Gajjar A., and Mulhern R.K. Early patterns of verbal memory impairment in children treated for medulloblastoma. Neuropsychology 20 1 (2006) 105-112
34. National Institute of Health. NIH Consensus Statement - Diagnosis and Treatment of Attention Deficit Hyperactivity Disorder (1998), National Institute of Health pp. 1-37
35. National Reading Panel. Teaching Children to Read: An Evidence Based Assessment of the Scientific Research Literature on Reading and its Implications for Reading Instruction (2000), U.S. Department of Health Human Services, Public Health Service, National Institute of Health, National Institute of Child Health and Human Development, Washington, D.C
36. Ness K.K., Gurney J.G., Zeltzer L.K., Leisenring W., Mulrooney D.A., Nathan P.C., Robison L.L., and Mertens A.C. The impact of limitations in physical, executive, and emotional function on health-related quality of life among adult survivors of childhood cancer: a report from the childhood cancer survivor study. Arch. Phys. Med. Rehabil. 89 1 (2008) 128-136
37. Oeffinger K., and McCabe M. Models for delivering survivorship care. J. Clin. Oncol. 24 32 (2006) 5117-5124
38. Oeffinger K.C., and Robison L.L. Childhood cancer survivors, late effects, and a new model for understanding survivorship. JAMA 297 24 (2007) 2762-2764
39. Packer R. Reduction of health status 7 years after addition of chemotherapy to cranio-spinal irradiation for medulloblastoma: a follow-up study on PNET-3 trial survivors. Curr. Neurol. Neurosci. Rep. 8 2 (2008) 111-113
40. Packer R., Goldwein J., Nicholson H.S., Vezina L.G., Allen J.C., Ris M.D., Muraszko K., Rorke L.B., Wara W.M., Cohen B.H., and Boyett J.M. Treatment of children with medulloblastomas with reduced-dose craniospinal radiation therapy and adjuvant chemotherapy: a children's cancer group study. J. Clin. Oncol. 17 7 (1999) 2127-2136
41. Palmer S.L., Gajjar A., Reddick W.E., Glass J.O., Kun L.E., Wu S., Xiong X., and Mulhern R.K. Predicting intellectual outcome among children treated with 35-40 Gy craniospinal irradiation for medulloblastoma. Neuropsychology 17 4 (2003) 548-555
42. Palmer S.L., Goloubeva O., Reddick W.E., Glass J.O., Gajjar A., Kun L., Merchant T.E., and Mulhern R.K. Patterns of intellectual development among survivors of pediatric medulloblastoma: a longitudinal analysis. J. Clin. Oncol. 19 8 (2001) 2302-2308
43. Palmer S.L., Reddick W.E., and Gajjar A. Understanding the cognitive impact on children who are treated for medulloblastoma. J. Pediatr. Psychol. 32 9 (2007) 1040-1049
44. Polderman T.J., Posthuma D., De Sonneville L.M., Stins J.F., Verhulst F.C., and Boomsma D.I. Genetic analyses of the stability of executive functioning during childhood. Biol. Psychol. 76 1-2 (2007) 11-20
45. Reeves C.B., Palmer S., Gross A.M., Simonian S.J., Taylor L., Willingham E., and Mulhern R.K. Brief report: sluggish cognitive tempo among pediatric survivors of acute lymphoblastic leukemia. J. Pediatr. Psychol. 32 9 (2007) 1050-1054
46. Ris M.D., Packer R., Goldwein J., Jones-Wallace D., and Boyett J.M. Intellectual outcome after reduced-dose radiation therapy plus adjuvant chemotherapy for medulloblastoma: a children's cancer group study. J. Clin. Oncol. 19 15 (2001) 3470-3476
47. Rutkowski S., Bode U., Deinlein F., Ottensmeier H., Warmuth-Metz M., Soerensen N., Graf N., Emser A., Pietsch T., Wolff J., Kortmann R., and Kuehl J. Treatment of early childhood medulloblastoma by postoperative chemotherapy alone. New Engl. J. Med. 352 10 (2005) 978-986
48. Schatz J., Kramer J.H., Ablin A., and Matthay K.K. Processing speed, working memory, and IQ: a developmental model of cognitive deficits following cranial radiation therapy. Neuropsychology 14 2 (2000) 189-200
49. Schultz K.A., Ness K.K., Whitton J., Recklitis C., Zebrack B., Robison L.L., Zeltzer L., and Mertens A.C. Behavioral and social outcomes in adolescent survivors of childhood cancer: a report from the childhood cancer survivor study. J. Clin. Oncol. 25 24 (2007) 3649-3656
50. Shanahan M.A., Pennington B.F., Yerys B.E., Scott A., Boada R., Willcutt E.G., Olson R.K., and DeFries J.C. Processing speed deficits in attention deficit/hyperactivity disorder and reading disability. J. Abnorm. Child Psychol. 34 5 (2006) 585-602
51. Shaywitz S.E., Morris R., and Shaywitz B.A. The education of dyslexic children from childhood to young adulthood. Annu. Rev. Psychol. 59 (2008) 451-475
52. Skinner R., Wallace W.H., and Levitt G. Therapy Based Long Term Follow Up: A Practice Statement (2005), United Kingdom Children's Cancer Study Group, Late Effects Group
53. Solanto M.V., Gilbert S.N., Raj A., Zhu J., Pope-Boyd S., Stepak B., Vail L., and Newcorn J.H. Neurocognitive functioning in AD/HD, predominantly inattentive and combined subtypes. J. Abnorm. Child Psychol. 35 5 (2007) 729-744
54. Steinlin M. The cerebellum in cognitive processes: supporting studies in children. Cerebellum 6 3 (2007) 237-241
55. Steinlin M., Imfeld S., Zulauf P., Boltshauser E., Lovblad K., Ridolfi-Luthy A., Perrig W., and Kaufmann F. Neuropsychological long-term sequelae after posterior fossa tumor resection during childhood. Brain 126 9 (2003) 1998-2008
56. Temple E., Deutsch G.K., Poldrack R.A., Miller S.L., Tallal P., Merzenich M.M., and Gabrieli J.D. Neural deficits in children with dyslexia ameliorated by behavioral remediation: evidence from functional MRI. Proc. Natl. Acad. Sci. USA 100 5 (2003) 2860-2865
57. Thomas P.R., Deutsch M., Kepner J.L., Boyett J.M., Krischer J., Aronin P., Albright L., Allen J.C., Packer R.J., Linggood R., Mulhern R., Stehbens J.A., Langston J., Stanley P., Duffner P., Rorke L., Cherlow J., Friedman H.S., Finlay J.L., Vietti T.J., and Kun L.E. Low-stage medulloblastoma: final analysis of trial comparing standard-dose with reduced-dose neuraxis irradiation. J. Clin. Oncol. 18 16 (2000) 3004-3011
58. Thompson S.J., Leigh L., Christensen R., Xiong X., Kun L.E., Heideman R.L., Reddick W.E., Gajjar A., Merchant T., Pui C.H., Hudson M.M., and Mulhern R.K. Immediate neurocognitive effects of methylphenidate on learning-impaired survivors of childhood cancer. J. Clin. Oncol. 19 6 (2001) 1802-1808
59. Vaquero E., Gomez C., Quintero E., Gonzalez-Rosa J., and Marquez J. Differential prefrontal-like deficit in children after cerebellar astrocytoma and medulloblastoma tumor. Behav. Brain Funct. 4 18 (2008) 10.1186/1744-9081-1184-1118